PARTENAR-IA | ENTREPRISE: Our funding program
for business R&D

Deadline to participate in the next selection round: November 12, 2020.

CQDM is launching a new program to fund activities carried out in companies that are part of collaborative R & D projects in artificial intelligence applicable to the biopharmaceutical sector.

The main eligibility criteria are:

  • Companies with a minimum of two Quebec SMEs or startups;
  • Project carried out with one or more research institution(s) such as universities, hospitals and CCTTs; minimum 20% of the project;
  • A minimum of one intern per year per company must be hired for the duration of the project;
  • Minimum industrial contribution of 25% (cash + in-kind);
  • Project duration: up to three years.

Funding:

  • Up to 50% of eligible expenses incurred in businesses and research institutions;
  • Maximum funding of $150,000 per eligible partner company, for a total of up to $600,000 (for a project value of $1.2M involving four companies).

Please contact Nadia Dubé at ndube@cqdm.org or Sébastien Bergeron at sbergeron@cqdm.org to discuss your project or to indicate your intent to apply.

For a summary of the program objectives and eligibility criteria, please consult the overview.

For more detailed information, please consult the call guide.